en

PRODUCT DETAIL

Zassida 25 mg/ml prášok na injekčnú suspenziu

Code 6692D
MA number 44/0047/21-S
Product Form: plv inu 1x150 mg (liek.inj.skl.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BC Pyrimidine analogues
L01BC07 Azacitidine
Shelf life: 36
Container: glass vial
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 23.02.2021
Validity: 23.02.2026
SPC: SPC_Zassida 25 mg_ml prášok na injekčnú suspenziu_12.2023.pdf  
PIL: PIL_Zassida 25 mg_ml prášok na injekčnú suspenziu_12.2023.pdf  
Safety feature Yes
Data update: 01.03.2021
eu-flag.png sk-flag.png